Markets

Actinium Pharmaceuticals Appoints Dr. Matt David As CFO

Oct 15, 2026 · 07:33 AM ET· updated 2h ago

Dr. David brings more than two decades of experience across biopharmaceutical operating leadership, healthcare investment banking and equity research. He joins Actinium from CorMedix Inc. (NASDAQ:CRMD), where he most

Why It Matters

Actinium hired a new money leader with lots of healthcare experience. This shows the company is serious about managing its finances well.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ATNM1.03

+0.06 (+5.68%)

CRMD7.57

+0.18 (+2.44%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.